RESUMEN
BACKGROUND: Kidney transplant recipients are a unique cohort in regard to SARS-CoV 2 susceptibility and clinical course, owing to their immunosuppressed state and propensity for kidney injury. The primary purpose of this study is to ascertain if, in kidney transplant recipients, SARS-CoV 2 infection impacts long term renal allograft function. METHODS: This retrospective, single-center study reviewed 53 kidney transplant recipients with a positive SARS-CoV-2 PCR at NMH from January 1, 2020 to June 30, 2020. RESULTS: Change in eGFR from baseline kidney function prior to infection to 90 days after the first positive SARS-CoV 2 test was +1.76%, -17.5% and -23.16% the mild, moderate and severe disease groups respectively. There was a significant decline in kidney function in the moderate and severe disease cohorts as compared to the mild disease cohort, with respective p values of p = 0.0002 and p = 0.021. Relative to the mild disease cohort, the moderate and severe disease cohorts also demonstrated significantly increased risk of developing AKI (66%, 85%), both with p values of P = 0.0001. CONCLUSIONS: Clinically severe SARS-CoV 2 infection is associated with greater risk of acute kidney injury and greater decline in renal allograft function at 90 days post infection, compared to mild disease.
Asunto(s)
Lesión Renal Aguda/etiología , Aloinjertos/virología , COVID-19/complicaciones , Trasplante de Riñón , Riñón/virología , SARS-CoV-2/aislamiento & purificación , Lesión Renal Aguda/fisiopatología , Aloinjertos/fisiopatología , COVID-19/diagnóstico , COVID-19/virología , Humanos , Riñón/fisiopatología , Persona de Mediana Edad , Estudios Retrospectivos , Receptores de TrasplantesRESUMEN
PURPOSE OF REVIEW: In this paper, we seek to review coronavirus disease 2019 (COVID-19) associated kidney injury with a focus on what is known about pathophysiology. RECENT FINDINGS: Kidney injury is a common complication of SARS-CoV-2 infection and is associated with increased morbidity and mortality. Acute tubular necrosis and glomerular injury are two common findings. Direct viral effect, endothelial dysfunction, and podocyte and tubular epithelial injury have been described. COVID-19-related glomerular injury may also be associated with high-risk APOL1 genotype. SUMMARY: Data on COVID-19 renal involvement have suggested novel mechanisms of kidney injury that need to be further elucidated. More data are needed on renal involvement in milder disease, renal-specific therapeutic interventions, and long-term sequelae.
Asunto(s)
Lesión Renal Aguda/etiología , Lesión Renal Aguda/fisiopatología , COVID-19/complicaciones , COVID-19/fisiopatología , Lesión Renal Aguda/genética , Lesión Renal Aguda/terapia , COVID-19/terapia , Genotipo , Humanos , Enfermedades Renales/etiología , Enfermedades Renales/genética , Enfermedades Renales/fisiopatología , Enfermedades Renales/terapiaRESUMEN
BACKGROUND: Studies have documented AKI with high-grade proteinuria in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In some patients, biopsies have revealed collapsing glomerulopathy, a distinct form of glomerular injury that has been associated with other viruses, including HIV. Previous patient reports have described patients of African ancestry who developed nephrotic-range proteinuria and AKI early in the course of disease. METHODS: In this patient series, we identified six patients with coronavirus disease 2019 (COVID-19), AKI, and nephrotic-range proteinuria. COVID-19 was diagnosed by a positive nasopharyngeal swab RT-PCR for SARS-CoV-2 infection. We examined biopsy specimens from one transplanted kidney and five native kidneys. Three of the six patients underwent genetic analysis of APOL1, the gene encoding the APOL1 protein, from DNA extracted from peripheral blood. In addition, we purified genomic DNA from paraffin-embedded tissue and performed APOL1 genotype analysis of one of the native biopsies and the donor kidney graft. RESULTS: All six patients were of recent African ancestry. They developed COVID-19-associated AKI with podocytopathy, collapsing glomerulopathy, or both. Patients exhibited generally mild respiratory symptoms, and no patient required ventilator support. Genetic testing performed in three patients confirmed high-risk APOL1 genotypes. One APOL1 high-risk patient developed collapsing glomerulopathy in the engrafted kidney, which was transplanted from a donor who carried a low-risk APOL1 genotype; this contradicts current models of APOL1-mediated kidney injury, and suggests that intrinsic renal expression of APOL1 may not be the driver of nephrotoxicity and specifically, of podocyte injury. CONCLUSIONS: Glomerular disease presenting as proteinuria with or without AKI is an important presentation of COVID-19 infection and may be associated with a high-risk APOL1 genotype.
Asunto(s)
Lesión Renal Aguda/etiología , Apolipoproteína L1/genética , Negro o Afroamericano , COVID-19/complicaciones , Glomérulos Renales/fisiopatología , SARS-CoV-2 , Lesión Renal Aguda/etnología , Lesión Renal Aguda/genética , Lesión Renal Aguda/fisiopatología , Negro o Afroamericano/genética , Apolipoproteína L1/fisiología , Biopsia , Nefropatías Diabéticas/complicaciones , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Hematuria/etiología , Humanos , Hipertensión/complicaciones , Glomérulos Renales/patología , Trasplante de Riñón , Masculino , Persona de Mediana Edad , Modelos Biológicos , Podocitos/patología , Podocitos/virología , Proteinuria/etiología , Riesgo , SARS-CoV-2/patogenicidad , Tropismo ViralRESUMEN
We report a case of a 50-year-old male with a history of HIV and kidney transplant who presented with SARS-CoV-2. We also present a review of COVID-19 cases in kidney transplant recipients.
Asunto(s)
Nefropatía Asociada a SIDA/cirugía , COVID-19/diagnóstico , Fallo Renal Crónico/cirugía , Trasplante de Riñón/efectos adversos , SARS-CoV-2/inmunología , Nefropatía Asociada a SIDA/complicaciones , Nefropatía Asociada a SIDA/tratamiento farmacológico , Nefropatía Asociada a SIDA/inmunología , Antirreumáticos/uso terapéutico , COVID-19/inmunología , COVID-19/virología , Prueba de Ácido Nucleico para COVID-19 , Rechazo de Injerto/inmunología , Rechazo de Injerto/prevención & control , Humanos , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Fallo Renal Crónico/inmunología , Masculino , Persona de Mediana Edad , ARN Viral/aislamiento & purificación , SARS-CoV-2/genética , SARS-CoV-2/aislamiento & purificación , Receptores de TrasplantesRESUMEN
The modern immunosuppression regimen has greatly improved short-term allograft outcomes but not long-term allograft survival. Complications associated with immunosuppression, specifically nephrotoxicity and infection risk, significantly affect graft and patient survival. Inducing and understanding pathways underlying clinical tolerance after transplantation are, therefore, necessary. We previously showed full donor chimerism and immunosuppression withdrawal in highly mismatched allograft recipients using a bioengineered stem cell product (FCRx). Here, we evaluated the gene expression and microRNA expression profiles in renal biopsy samples from tolerance-induced FCRx recipients, paired donor organs before implant, and subjects under standard immunosuppression (SIS) without rejection and with acute rejection. Unlike allograft samples showing acute rejection, samples from FCRx recipients did not show upregulation of T cell- and B cell-mediated rejection pathways. Gene expression pathways differed slightly between FCRx samples and the paired preimplantation donor organ samples, but most of the functional gene networks overlapped. Notably, compared with SIS samples, FCRx samples showed upregulation of genes involved in pathways, like B cell receptor signaling. Additionally, prediction analysis showed inhibition of proinflammatory regulators and activation of anti-inflammatory pathways in FCRx samples. Furthermore, integrative analyses (microRNA and gene expression profiling from the same biopsy sample) identified the induction of regulators with demonstrated roles in the downregulation of inflammatory pathways and maintenance of tissue homeostasis in tolerance-induced FCRx samples compared with SIS samples. This pilot study highlights the utility of molecular intragraft evaluation of pathways related to FCRx-induced tolerance and the use of integrative analyses for identifying upstream regulators of the affected downstream molecular pathways.
Asunto(s)
Rechazo de Injerto/genética , Supervivencia de Injerto/genética , Trasplante de Células Madre Hematopoyéticas , Trasplante de Riñón , MicroARNs/genética , Tolerancia al Trasplante/genética , Tolerancia al Trasplante/inmunología , Adulto , Anciano , Linfocitos B/inmunología , Quimerismo , Regulación hacia Abajo , Femenino , Expresión Génica , Ontología de Genes , Humanos , Terapia de Inmunosupresión , Masculino , Persona de Mediana Edad , Proyectos Piloto , Periodo Posoperatorio , Periodo Preoperatorio , ARN Mensajero/metabolismo , Transducción de Señal/genética , Linfocitos T/inmunología , Transcriptoma , Trasplante Homólogo , Regulación hacia Arriba , Adulto JovenRESUMEN
BACKGROUND: The Accreditation Council for Graduate Medical Education (ACGME) introduced new work hour limitations in July 2011. PURPOSES: The aim is to assess internal medicine residents' perspectives on the impact of these limitations on their ability to discharge patient care duties. METHODS: An anonymous survey was administered to 158 medicine residents in an urban university-affiliated internal medicine residency program. Residents' perspectives on various aspects of patient care were recorded on a 5-point Likert-type scale. RESULTS: The response rate was 62%. The majority of residents (80%) agreed that patients had adequate continuity of care. Most residents agreed that they had enough time to follow up on consult notes (64% agreed) and investigations (80% agreed) daily. Most PGY-1 residents (59%) reported having enough time to prepare sign-outs. Most (60%) residents felt that reducing handoffs would improve patient care. CONCLUSIONS: Most residents believe that the new work hour limitations would continue to uphold patient safety, but handoffs in care must be restricted.